Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2025 06:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics Shares Breakthrough Preclinical Data for Non-Invasive Treatment of Parkinson’s Disease Using a Brain Targeted AAV Gene Therapy at the European Society of Gene & Cell Therapy 32nd Annual Congress

Preclinical data demonstrates that Shape’s engineered AAV5 variant, SHP-DB1, efficiently targets the NHP brain after intravenous injection and transduces >95% of neurons in the Parkinson's...
September 26, 2025 09:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics Announces Multiple Oral Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress

Shape Therapeutics to present at the ESGCT 32nd congress on an RNA-targeting gene therapy for Parkinson's Disease and a novel CNS AAV capsid.
November 30, 2023 08:00 ET | Source: Shape Therapeutics, Inc.

ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target

ShapeTX announces the expansion of its drug discovery partnership with Roche with new target
September 07, 2023 17:00 ET | Source: Shape Therapeutics, Inc.; Otsuka

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

TOKYO and SEATTLE, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announce...